Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis

  1. Carey, L.A.
  2. Loirat, D.
  3. Punie, K.
  4. Bardia, A.
  5. Diéras, V.
  6. Dalenc, F.
  7. Diamond, J.R.
  8. Fontaine, C.
  9. Wang, G.
  10. Rugo, H.S.
  11. Hurvitz, S.A.
  12. Kalinsky, K.
  13. O’Shaughnessy, J.
  14. Loibl, S.
  15. Gianni, L.
  16. Piccart, M.
  17. Zhu, Y.
  18. Delaney, R.
  19. Phan, S.
  20. Cortés, J.
Aldizkaria:
npj Breast Cancer

ISSN: 2374-4677

Argitalpen urtea: 2022

Alea: 8

Zenbakia: 1

Mota: Artikulua

DOI: 10.1038/S41523-022-00439-5 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus